Navigation Links
FDA Approves Hi-Flex Mobile Bearing Knee for Active Adults
Date:1/3/2008

Dr. Mitchell Sheinkop first to perform implant in February

CHICAGO, Jan. 2 /PRNewswire/ -- Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago. Last week, the FDA approved the Zimmer Holdings knee, which is heralded as the next generation of knee prostheses for active adults, especially amateur and professional athletes. Dr. Sheinkop was one of eight physician investigators in the United States who participated in the clinical trial proceeding FDA approval.

The main difference between a fixed bearing, or traditional knee replacement, and a mobile bearing knee is that the articulating surface is free to rotate slightly along with the patient's natural movement.

"The design of this knee allows for better range of motion and improved flexibility for daily activities, whether around the home, at work or during sports and exercise," says Dr. Sheinkop, an orthopedic surgeon and Director of Joint Replacement at the NOHC. "The knee is designed for patients who want high-flexion and have demanding lifestyles/habits. If you want to do deep knee bends, this is the knee you should choose."

Just ask athlete and lawyer Charles Zarzecki, who has a work hard, play hard mentality. Zarzecki, age 50, participated in the clinical trial for the Next Gen LPS-Flex mobile bearing knee and now plays in a Chicago-based USA Hockey team that placed 2nd in the 2007 National Pond Hockey Championships.

"In 2004, I was playing competitive basketball and there was little cartilage left in my knee," says Zarzecki. "After four arthroscopic surgeries, my leg still bowed out, and I knew it was time to do something if I wanted to continue my active lifestyle." Besides hockey, Zarzecki's knee allows him to participate in golfing, biking, spinning and snow skiing.

In 2001, Dr. Sheinkop was first expos
'/>"/>

SOURCE The Neurologic & Orthopedic Hospital of Chicago
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 TayganPoint Consulting Group, ... that President and co-founder John Cassimatis was named ... Winners for 2014, recognizing the region’s top healthcare ... emerging executive of the year. , The Innovation ... sciences that continue to shape the medical industry ...
(Date:9/18/2014)... GA (PRWEB) September 18, 2014 Ben ... the Alex Ormond, Jr. Leadership Award by the Savannah ... improving healthcare and wellness throughout the nation and especially ... receive this award,” said Ben. “The Savannah Science Seminar ... 65 years and multiple generations have gone through the ...
(Date:9/18/2014)... have developed a new method to study Ebola virus ... Wildlife Conservation Society (WCS)-led research, published today in the ... use of fecal samples from wild great apes to ... virus. This represents a new tool for performing large, ... Ebola virus is studied and improve our understanding of ...
(Date:9/18/2014)... (September 18, 2014) The National Institutes of Health ... a four-year, $1.3 million grant to the Los Angeles ... research and development of a vaccine to protect patients ... Staphylococcus aureus (MRSA). , The National ... NIH awarded the grant to LA BioMed infectious disease ...
(Date:9/18/2014)... trying to develop tools that would allow them to ... moment a neuron fires to the resulting behavior in ... are working to develop a range of new tools ... one such tool that provides a new way of ... worka collaboration between Viviana Gradinaru (BS ,05), assistant professor ...
Breaking Medicine News(10 mins):Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:Sensing neuronal activity with light 2Health News:Sensing neuronal activity with light 3Health News:Sensing neuronal activity with light 4Health News:Sensing neuronal activity with light 5
... Brophy Marcus HealthDay Reporter , WEDNESDAY, Oct. 5 ... after a kidney transplant allows some patients to cast away ... new organ, according to a small new study from the ... in the United States and while they can greatly improve ...
... Steven Reinberg HealthDay Reporter , WEDNESDAY, Oct. 5 ... tip-top health may have a greater risk of developing dementia ... Oct. 5 issue of the journal Neurology . ... simple tool for doctors to determine a person,s risk of ...
... WEDNESDAY, Oct. 5 (HealthDay News) -- The death toll from ... risen to 18, and a total of 100 people have ... Control and Prevention reported late Tuesday. The agency said ... 14, more cases might still emerge since Listeria monocytogenes ...
... from Mount Sinai School of Medicine have found high ... (AGEs) in infants. Excessive food AGEs, through both maternal ... children,s risk for diseases such as diabetes from a ... adults found that cutting back on processed, grilled, and ...
... (HealthDay News) -- Scientists who taught monkeys to use their ... virtual body) and to identify the texture of virtual objects ... for people who,ve suffered crippling spinal injuries. "Someday in ... technology not only to move their arms and hands and ...
... (October 5, 2011)Prostate cancer is the most common cancer ... the second leading cause of cancer-related deaths in this ... their prostate, followed by radiation therapy applied to their ... once situated. The most common technique of ...
Cached Medicine News:Health News:Stem Cell Therapy Might Help Kidney Transplant Patients 2Health News:Stem Cell Therapy Might Help Kidney Transplant Patients 3Health News:Stem Cell Therapy Might Help Kidney Transplant Patients 4Health News:Gauging General Health as 'Poor' May Point to Dementia Risk 2Health News:18 Deaths From Cantaloupe-Linked Listeria Outbreak: CDC 2Health News:18 Deaths From Cantaloupe-Linked Listeria Outbreak: CDC 3Health News:New study shows inflammatory food toxins found in high levels in infants 2Health News:New study shows inflammatory food toxins found in high levels in infants 3Health News:Monkeys Use Brain Power, Not Hands, to 'Move' Virtual Objects 2Health News:Fox Chase researchers improve accuracy of IMRT delivery in post-prostatectomy patients 2Health News:Fox Chase researchers improve accuracy of IMRT delivery in post-prostatectomy patients 3
(Date:9/18/2014)... Australia , Sept. 18, 2014 Veterinary ... of Dr. Ashraf Hanna , M.D., Ph.D., and ... Board of Directors. Dr. Hanna is the Vice President ... Chief Financial Officer for the Genentech Foundation, while Dr. ... Head of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... 18, 2014  Spring Bank Pharmaceuticals, Inc., a ... treatment of RNA viruses, today announced a research ... for animal testing of the Company,s lead compound, ... "Special Pathogens," against which currently there are no ... Spring Bank,s proprietary Small Molecule Nucleic Acid ...
(Date:9/18/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced the first presentation of positive safety and ... Investigation of Collagenase Optimizing the Resolution of Dupuytrens) ... histolyticum (CCH) for the treatment of two Dupuytren,s ... the study examined expanded flexibility with timing of ...
Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
... Cobalt Binding (ACB®) Test is a clinical ... (IMA®) by measuring the cobalt binding capacity ... First identified in the early 1990s, IMA ... contact with ischemic tissue in the heart. ...
Inquire...
Medicine Products: